| Active substance | givinostat |
| Holder | Italfarmaco S.p.A. |
| Status | Running |
| Indication | Duvyzat is indicated for the treatment of Duchenne muscular dystrophy (DMD) in ambulant patients, aged 6 years and older, and with concomitant corticosteroid treatment. |
| Public documents | |
|
Informed consent for parents / legal giardians (template) Informed consent for parents / legal giardians (template) - amendment 01 |
|
|
Informed consent for youngest children (7 - 11 years old) Informed consent for children (7 - 11 years old) - amendment 01 |
|
|
Informed consent for oldest children (12 - 17 years old) Informed consent for oldest children (12 - 17 years old) - amendment 01 |
|
|
Informed consent for adult patients (template) Informed consent for adult patients (template) - amendment 01 Informed consent for adult patients (template) - amendment 02 |
|
|
Informed consent for adult patients (assent form) Informed consent for adult patients (assent form) - amendment 01 |
|
| Last update | 12/02/2026 |